Pelle, M.C.; Provenzano, M.; Zaffina, I.; Pujia, R.; Giofrè, F.; Lucà , S.; Andreucci, M.; Sciacqua, A.; Arturi, F.
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment. Life 2022, 12, 29.
https://doi.org/10.3390/life12010029
AMA Style
Pelle MC, Provenzano M, Zaffina I, Pujia R, Giofrè F, Lucà S, Andreucci M, Sciacqua A, Arturi F.
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment. Life. 2022; 12(1):29.
https://doi.org/10.3390/life12010029
Chicago/Turabian Style
Pelle, Maria Chiara, Michele Provenzano, Isabella Zaffina, Roberta Pujia, Federica Giofrè, Stefania Lucà , Michele Andreucci, Angela Sciacqua, and Franco Arturi.
2022. "Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment" Life 12, no. 1: 29.
https://doi.org/10.3390/life12010029
APA Style
Pelle, M. C., Provenzano, M., Zaffina, I., Pujia, R., Giofrè, F., Lucà , S., Andreucci, M., Sciacqua, A., & Arturi, F.
(2022). Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment. Life, 12(1), 29.
https://doi.org/10.3390/life12010029
